• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响早期前列腺癌患者治疗选择的信息:一项综述

Information that affects patients' treatment choices for early stage prostate cancer: a review.

作者信息

Feldman-Stewart Deb, Brundage Michael D, Tong Christine

机构信息

Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada.

出版信息

Can J Urol. 2011 Dec;18(6):5998-6006.

PMID:22166326
Abstract

INTRODUCTION

We conducted a systematic review of primary evidence to clarify what information influences treatment selection by patients with early stage prostate cancer.

MATERIALS AND METHODS

We conducted a systematic review of the Web of Knowledge, using the ALL DATABASES option. Papers were then triaged out on the basis of the title and/or abstract, leaving 120 papers. Reviewing the full papers resulted in a final corpus of 21 papers.

RESULTS

The data suggest that patients typically balance potential benefits against potential side effects but in a complex way with large variation across patients. For some patients, potential benefits relate to chances of survival but, for others, relate to control over cancer spread. The most common potential harm is effect on bladder functioning but even that is not a concern of all patients. Similarly, potential impact on bowel and on sexual functioning affects some patients' decisions but not others. Patient decisions are also affected by information not typically identified as affecting this decision. These include aspects of treatment and decision processes, competencies, and others' opinions, again, with wide variation across patients. The patient's view of which information items affect his decision may also change over time, consistent with a dynamic decision-making process.

CONCLUSIONS

Decision support interventions are needed to optimally tailor information for decision-making to the individual patient, and should be designed to accommodate the illustrated variation in patients' needs.

摘要

引言

我们对主要证据进行了系统综述,以阐明哪些信息会影响早期前列腺癌患者的治疗选择。

材料与方法

我们使用“所有数据库”选项对《科学网》进行了系统综述。然后根据标题和/或摘要对论文进行筛选,留下120篇论文。对全文进行评审后,最终形成了21篇论文的语料库。

结果

数据表明,患者通常会权衡潜在益处与潜在副作用,但方式复杂,患者之间差异很大。对一些患者来说,潜在益处与生存机会有关,但对另一些患者来说,则与控制癌症扩散有关。最常见的潜在危害是对膀胱功能的影响,但即便如此,也并非所有患者都担心这一点。同样,对肠道和性功能的潜在影响会影响一些患者的决策,但不会影响其他患者。患者的决策还会受到通常未被视为影响该决策的信息的影响。这些信息包括治疗和决策过程的各个方面、能力以及他人的意见,同样,患者之间差异很大。患者对哪些信息项会影响其决策的看法也可能随时间而改变,这与动态决策过程是一致的。

结论

需要决策支持干预措施,以便为个体患者优化决策所需的信息,并应设计这些措施以适应患者需求中所显示的差异。

相似文献

1
Information that affects patients' treatment choices for early stage prostate cancer: a review.影响早期前列腺癌患者治疗选择的信息:一项综述
Can J Urol. 2011 Dec;18(6):5998-6006.
2
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.选择观察等待或主动监测作为治疗方法的成年人的经历:一项定性系统评价。
JBI Database System Rev Implement Rep. 2016 Feb;14(2):174-255. doi: 10.11124/jbisrir-2016-2270.
6
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD001431. doi: 10.1002/14651858.CD001431.pub3.
7
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
8
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2001(3):CD001431. doi: 10.1002/14651858.CD001431.
9
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.计算机和其他电子戒烟辅助手段的有效性和成本效益:系统评价和网络荟萃分析。
Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380.
10
Interventions for improving the adoption of shared decision making by healthcare professionals.提高医疗保健专业人员采用共同决策的干预措施。
Cochrane Database Syst Rev. 2010 May 12(5):CD006732. doi: 10.1002/14651858.CD006732.pub2.

引用本文的文献

1
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.炎症性疾病患者在先进治疗药物产品(ATMP)篮子试验中电子患者报告结局(ePRO)解决方案的开发和可用性测试。
J Patient Rep Outcomes. 2023 Oct 9;7(1):98. doi: 10.1186/s41687-023-00634-3.
2
Usability testing of an electronic patient-reported outcome system linked to an electronic chemotherapy prescribing and patient management system for patients with cancer.针对癌症患者,对与电子化疗处方及患者管理系统相连接的电子患者报告结局系统进行可用性测试。
Heliyon. 2023 May 23;9(6):e16453. doi: 10.1016/j.heliyon.2023.e16453. eCollection 2023 Jun.
3
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer.
社会生态因素对低危局限性前列腺癌男性治疗决策的影响。
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13697. doi: 10.1111/ecc.13697. Epub 2022 Sep 22.
4
Cancer Patients Numeracy and Preferences for Information Presentation-a Survey Among German Cancer Patients.癌症患者的数字能力及对信息呈现方式的偏好——一项针对德国癌症患者的调查
J Cancer Educ. 2020 Feb;35(1):22-27. doi: 10.1007/s13187-018-1435-4.
5
A standardized analysis of the current surgical and non-surgical treatment selection process for men with localized prostate cancer.对局限性前列腺癌男性患者当前手术及非手术治疗选择过程的标准化分析。
J Robot Surg. 2018 Jun;12(2):215-221. doi: 10.1007/s11701-018-0796-3. Epub 2018 Mar 16.
6
Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.早期前列腺癌前列腺切除术与放疗(PREPaRE)研究:一项局部前列腺癌男性治疗决策混合方法研究的方案。
BMJ Open. 2017 Nov 3;7(11):e018403. doi: 10.1136/bmjopen-2017-018403.
7
A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.局部前列腺癌疗效试验的核心结局集:文献系统评价及通过访谈和德尔菲调查让利益相关者参与的方案
Trials. 2015 Mar 4;16:76. doi: 10.1186/s13063-015-0598-0.
8
Radiogenomics: radiobiology enters the era of big data and team science.放射基因组学:放射生物学进入大数据和团队科学时代。
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):709-13. doi: 10.1016/j.ijrobp.2014.03.009.
9
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin.前列腺癌治疗中的跨学科决策 - 柏林夏里特大学附属医院跨学科前列腺癌中心的 5 年时间趋势。
BMC Med Inform Decis Mak. 2013 Aug 5;13:83. doi: 10.1186/1472-6947-13-83.